Suling Liu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Cancer Stem Cells

Top Venues

Cancer research

Nature cell biology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Ma, Lu Zhang, Weilong Chen, Zhaoxia Chang, Juchuanli Tu, Yuanyuan Qin, Yuwen Yao, Mengxue Dong, Jiajun Ding, Siqin Li, Fengkai Li, Qiaodan Deng, Yifei Yang, Tingting Feng, Fanrong Zhang, Xiying Shao, Xueyan He, Lixing Zhang, Guohong Hu, Quentin Liu, Yi-Zhou Jiang, Shu Zhu, Zhi Xiao, Dan Su, Tong Liu, Suling Liu
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein & cell 15 (6) (2024)
Wei Ma, Lu Zhang, Weilong Chen, Zhaoxia Chang, Juchuanli Tu, Yuanyuan Qin, Yuwen Yao, Mengxue Dong, Jiajun Ding, Siqin Li, Fengkai Li, Qiaodan Deng, Yifei Yang, Tingting Feng, Fanrong Zhang, Xiying Shao, Xueyan He, Lixing Zhang, Guohong Hu, Quentin Liu, Yi-Zhou Jiang, Shu Zhu, Zhi Xiao, Dan Su, Tong Liu, Suling Liu
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein & cell 15 (6) (2024)
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guo-Hong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. Cancer research 84 (14) (2024)
Jiahui Xu, Suling Liu
Cell origin of BRCA2-mutant breast cancer. Nature cell biology 26 (1) (2024)
Jiahui Xu, Suling Liu
Cell origin of BRCA2-mutant breast cancer. Nature cell biology (2024)
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guo-Hong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. Cancer research 84 (14) (2024)
Wei Ma, Lu Zhang, Weilong Chen, Zhaoxia Chang, Juchuanli Tu, Yuanyuan Qin, Yuwen Yao, Mengxue Dong, Jiajun Ding, Siqin Li, Fengkai Li, Qiaodan Deng, Yifei Yang, Tingting Feng, Fanrong Zhang, Xiying Shao, Xueyan He, Lixing Zhang, Guohong Hu, Quentin Liu, Yi-Zhou Jiang, Shu Zhu, Zhi Xiao, Dan Su, Tong Liu, Suling Liu
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein & cell 15 (6) (2024)
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guo-Hong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
IL1R2 blockade alleviates immunosuppression and potentiates anti-PD-1 efficacy in triple-negative breast cancer. Cancer research (2024)
Wei Ma, Lu Zhang, Weilong Chen, Zhaoxia Chang, Juchuanli Tu, Yuanyuan Qin, Yuwen Yao, Mengxue Dong, Jiajun Ding, Siqin Li, Fengkai Li, Qiaodan Deng, Yifei Yang, Tingting Feng, Fanrong Zhang, Xiying Shao, Xueyan He, Lixing Zhang, Guohong Hu, Quentin Liu, Yi-Zhou Jiang, Shu Zhu, Zhi Xiao, Dan Su, Tong Liu, Suling Liu
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein & cell 15 (6) (2024)
Jiahui Xu, Suling Liu
Cell origin of BRCA2-mutant breast cancer. Nature cell biology 26 (1) (2024)
Mingming Wu, Xiao Zhang, Weijie Zhang, Yi-Shiou Chiou, Wenchang Qian, Xiangtian Liu, Min Zhang, Hong Yan, Shilan Li, Tao Li, Xinghua Han, Pengxu Qian, Suling Liu, Yue-Yin Pan, Peter E Lobie, Tao Zhu
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis. Nature communications 13 (1) (2022)
Dandan Sheng, Wei Ma, Rui Zhang, Lei Zhou, Qiaodan Deng, Juchuanli Tu, Weilong Chen, Fuchuang Zhang, Nailong Gao, Mengxue Dong, Dong Wang, Fengkai Li, Yin Liu, Xueyan He, Shengzhong Duan, Lixing Zhang, Tong Liu, Suling Liu
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. Journal for immunotherapy of cancer 10 (5) (2022)
Cuicui Liu, Jiankun Qiang, Qiaodan Deng, Jie Xia, Lu Deng, Lei Zhou, Dong Wang, Xueyan He, Ying Liu, Botao Zhao, Jinhui Lv, Zuoren Yu, Qun-Ying Lei, Zhi-Ming Shao, Xiao-Yong Zhang, Lixing Zhang, Suling Liu
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression. Cancer research 81 (23) (2021)
Fengkai Li, Jiahui Xu, Suling Liu
Cancer Stem Cells and Neovascularization. Cells 10 (5) (2021)
Jiahui Xu, Xiaoli Yang, Qiaodan Deng, Cong Yang, Dong Wang, Guojuan Jiang, Xiaohong Yao, Xueyan He, Jiajun Ding, Jiankun Qiang, Juchuanli Tu, Rui Zhang, Qun-Ying Lei, Zhi-Min Shao, Xiu-Wu Bian, Huiying Zhao, Lixing Zhang, Suling Liu
TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer. Nature communications 12 (1) (2021)
Guojuan Jiang, Juchuanli Tu, Lei Zhou, Mengxue Dong, Jue Fan, Zhaoxia Chang, Lixing Zhang, Xiu-Wu Bian, Suling Liu
Single-cell transcriptomics reveal the heterogeneity and dynamic of cancer stem-like cells during breast tumor progression. Cell death & disease 12 (11) (2021)
Yuanyuan Qin, Weilong Chen, Guojuan Jiang, Lei Zhou, Xiaoli Yang, Hongqi Li, Xueyan He, Han-Lin Wang, Yu-Bo Zhou, Shenglin Huang, Suling Liu
Interfering MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer. Science advances 6 (8) (2020)
Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong, Jin Ye, Lei Song, Yunzhi Wang, Qingqing Li, Benjie Shan, Yizhou Jiang, Hongqi Li, Zhiming Shao, Guido Kroemer, Huafeng Zhang, Li Bai, Tengchuan Jin, Chao Wang, Yuting Ma, Yongping Cai, Chen Ding, Suling Liu, Yue-Yin Pan, Wei Jiang, Rongbin Zhou
Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Nature cell biology 22 (6) (2020)
Lixing Zhang, Jiankun Qiang, Xiaoli Yang, Dong Wang, Adeel Ur Rehman, Xueyan He, Weilong Chen, Dandan Sheng, Lei Zhou, Yi-Zhou Jiang, Tao Li, Ying Du, Jing Feng, Xin Hu, Jian Zhang, Xi-Chun Hu, Zhi-Ming Shao, Suling Liu
IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 Stability. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7 (1) (2019)
Jing Zhang, Yu Yang, Shen'ao Zhou, Xueyan He, Xuan Cao, Chenlu Wu, Hong Hu, Jie Qin, Gang Wei, Huayi Wang, Suling Liu, Liming Sun
Membrane-bound TNF mediates microtubule-targeting chemotherapeutics-induced cancer cytolysis via juxtacrine inter-cancer-cell death signaling. Cell death and differentiation 27 (5) (2019)
Xi Jin, Xiao-En Xu, Yi-Zhou Jiang, Yi-Rong Liu, Wei Sun, Ya-Jie Guo, Yi-Xing Ren, Wen-Jia Zuo, Xin Hu, Sheng-Lin Huang, Hong-Jie Shen, Fei Lan, Yun-Fei He, Guo-Hong Hu, Gen-Hong Di, Xiang-Huo He, Da-Qiang Li, Suling Liu, Jinha Yu
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science advances 5 (3) (2019)
Lu Deng, Xinlei Gao, Bingjie Liu, Xueyan He, Jiahui Xu, Jiankun Qiang, Qingfa Wu, Suling Liu
NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway. Cell death & disease 9 (12) (2018)
Weilong Chen, Yuanyuan Qin, Dong Wang, Lei Zhou, Yin Liu, Sheng Chen, Liang Yin, Yaoxing Xiao, Xiao-Hong Yao, Xiaoli Yang, Wei Ma, Weifeng Chen, Xueyan He, Lixing Zhang, Qifeng Yang, Xiuwu Bian, Zhi-Ming Shao, Suling Liu
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS biology 16 (7) (2018)
Lei Zhou, Dandan Sheng, Qiaodan Deng, Dong Wang, Suling Liu
Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells. Cancer communications (London, England) 38 (1) (2018)